title: Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
abstract: Hydroxamate-based chelators of iron are potent inhibitors of in vitro growth of Plasmodium falciparum. Two types of such chelators, the natural desferrioxamine and the synthetic reversed siderophore RSFileum2, are prototypes of antimalarial agents whose action spectra differ in the speed of action, stage dependence, and degree of reversibility of effects. This work explores the possibility of improving the antimalarial efficacy of these agents by using them in various combinations on in vitro cultures of P. falciparum. Growth assessment was based both on total nucleic acid synthesis and on parasitemia. The results indicate that the synthetic reversed siderophore more than complements the antimalarial action of desferrioxamine when applied during either ring, trophozoite, or mixed stages. The combined drug effects were significantly higher than the additive effect of the individual drugs. Qualitatively similar results were obtained for both reversible effects and irreversible (i.e., sustained) effects. Following an 8-h window of exposure the combined drug treatment caused parasite growth arrest and prevented its recovery, even 3 days after the treatment. The fact that such a combination of iron chelators displays a wider action spectrum than either drug alone has implications for the design of chemotherapy regimens.
authors.affiliation: Department of Parasitology, Kuvin Center for Infectious and Tropical Diseases, Hadassah Medical School, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Golenser
authors.forename: A
authors.initials: A
authors.lastname: Tsafack
authors.forename: Y
authors.initials: Y
authors.lastname: Amichai
authors.forename: J
authors.initials: J
authors.lastname: Libman
authors.forename: A
authors.initials: A
authors.lastname: Shanzer
authors.forename: Z I
authors.initials: ZI
authors.lastname: Cabantchik
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002478:Cells, Cultured; D003676:Deferoxamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006877:Hydroxamic Acids; D007502:Iron Chelating Agents / Q000494:pharmacology*; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000254:growth & development
chemical_list: D000962:Antimalarials; D006877:Hydroxamic Acids; D007502:Iron Chelating Agents; C088564:RSFileu m2; D003676:Deferoxamine